ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.Healios K.K, Riken, Osaka University
Munich (DE) Central Division - Section · UPC-001559
This case concerns a revocation action regarding European Patent No. EP3056563, owned by Healios K.K., Riken, and Osaka University, with Astellas Institute for Regenerative Medicine as the claimant. Following an interim conference held on 13 March 2024 via video conference, the judge-rapporteur issued procedural decisions on the admissibility of evidence and the value of the dispute. The court admitted a second declaration (D18) into the proceedings subject to conditions, and set the value of the dispute at 4,000,000 EUR for the purpose of applying the scale of ceilings for recoverable costs.